Find your next paid study

University of UtahNCT06857916

~$10 – $750

Actual pay is set by the research site.

Chronic PainSchizophreniaPsychotic Disorders+2 more

Exploring the Efficacy of Cognitive Behavioral Therapy for Chronic Pain in Veterans With Serious Mental Illness

Chronic musculoskeletal pain has a highly negative impact on Veterans, especially those with serious mental illness (SMI). Chronic musculoskeletal pain leads t…

VA Office of Research and DevelopmentNCT06758414

~$10 – $675

Actual pay is set by the research site.

Diabetic Foot UlcerVenous Leg Ulcer

A Randomized Post-Market Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating Diabetic Foot Ulcers (DFU) and SanoGraft® in Treating Venous Leg Ulcers (VLU) to SOC Treatment

The purpose of this study is to compare Pellograft to standard of care modalities in treating diabetic foot ulcers in human subjects, and to compare Sanograft …

~$10 – $1,125

Actual pay is set by the research site.

SurgenexNCT06515093

Phase 3

A Double-blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Oral Nerandomilast Treatment in Patients With Systemic Sclerosis (SSc)

Nerandomilast is being developed to help people with systemic sclerosis by potentially improving symptoms and slowing disease progression. This study is open t…

Systemic Sclerosis

Boehringer IngelheimNCT07497087

~$50 – $2,250

Actual pay is set by the research site.

Monitoring the Use of Collagen Dura Membrane - Repair (DMR) in the Post-market Phase

Monitoring the Use of Collagen Dura Regeneration Membrane - Repair (DMR) in the Post-market Phase.

Repair of Dura Mater

Collagen MatrixNCT07371091

~$10 – $1,050

Actual pay is set by the research site.

Non Small Cell Lung Cancer (NSCLC)

A Phase 2, Open-Label, Multicenter Study to Investigate the Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Lung Cancer Resection

The aim of this Phase 2 study is to investigate the efficacy and safety of a single dose of LS301-IT, a novel fluorescence imaging agent developed by Integro T…

Integro TheranosticsNCT07276789

~$75 – $3,000

Actual pay is set by the research site.

Lung InflammationExperimental Lung Inflammation

Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air for 6.6 Hours at Rest in Healthy Young Adults.

The primary purpose of this study is to measure pulmonary function, symptoms, and pulmonary inflammatory responses in healthy young adults during and immediate…

Environmental Protection Agency (EPA)NCT06943989

~$10 – $1,050

Actual pay is set by the research site.

An Observational Study to Assess Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

Background: SBMA is an inherited chronic disease. It affects males in mid to late adulthood. It causes slowly progressive weakness of muscles and hand tremors…

Spinal and Bulbar Muscular AtrophyKennedys DiseaseMotor Neuron Disease

National Institute of Neurological Disorders and Stroke (NINDS)NCT04944940

~$10 – $675

Actual pay is set by the research site.

A Phase 2, Double-blind, Randomized, Active-controlled Evaluation of the Safety, Tolerability, Pharmacokinetics and Efficacy of LBP-EC01 in the Treatment of Acute Uncomplicated Urinary Tract Infection Caused by Drug Resistant E. Coli

This is a Phase 2 superiority study of LBP-EC01, a recombinant bacteriophage cocktail, with an initial open-label 3-arm pharmacokinetic (PK) lead-in portion of…

Urinary Tract Infections

Locus BiosciencesNCT05488340

~$75 – $2,800

Actual pay is set by the research site.

Assessment of a Connected-health, Pressure Monitoring Technology for Improving Clinical Outcomes of Compression Therapy in the Treatment of Venous Leg Ulcers

This study evaluates the effectiveness of a connected-health, pressure monitoring technology (Tight Alright) to improve clinical outcomes of compression therap…

Venous Leg Ulcers (VLUs)

Feeltect LimitedNCT07152717

~$10 – $1,050

Actual pay is set by the research site.

High-Risk Localized Prostate Cancer

A Phase II Non-blinded Randomized Study Comparing External Beam Radiotherapy (EBRT), 177Lu-PSMA-617, and Short Term Androgen Deprivation Therapy (ADT) Versus EBRT and Long Term ADT in Men With High Risk Localized Prostate Cancer

This research is being done to find out if the study drug, 177Lu-PSMA-617, given before and during standard of care External Beam Radiation Therapy (EBRT) trea…

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07550517

~$75 – $2,000

Actual pay is set by the research site.

Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

This is an open-label, dose escalation and expansion, multi-center phase 2 study evaluating the safety and efficacy of SR-8541A administered orally in combinat…